Claims
- 1. A method for inhibiting the growth of cancerous and precancerous cell populations comprising the step of applying a therapeutic amount of eugenol to said cell population for a sufficient time to observe arrest of population growth.
- 2. The method of claim 1 further comprising the step of applying a therapeutic amount of 2-ME in combination with said amount of eugenol to said cell population.
- 3. The method of claim 1 wherein said cancerous cell populations are prostate cancer cells.
- 4. A therapeutic agent useful in the prevention and treatment of cancerous tumors comprising eugenol and 2-methoxyestradiol.
- 5. The therapeutic agent of claim 4 wherein said cancerous tumors are prostate cancer tumors.
- 6. A therapeutic agent for the prevention and treatment of enlarged, non-cancerous prostage tissues comprising a therapeutic dossage of 2-methoxyestradiol.
- 7. The therapeutic agent of claim 6 further comprising a therapeutic dossage of eugenol.
- 8. A method for preventing the development of, or for treating existing enlarged, non-cancerous prostate glands in mammals comprising the steps of administering a therapeutic dossage of 2-methoxyestradiol.
- 9. The method of claim 8 further comprising the administration of a therapeutic dossage of eugenol in combination with said 2-methoxyestradiol.
CITATION TO PRIOR APPLICATION
[0001] This is a continuation-in-part with respect to U.S. application, Ser. No. 09/527283, filed MAR. 17, 2000 from which priority is claimed under 35 U.S.C. § 120 and under provisions of the Patent Cooperation Treaty. This is also a continuation-in-part with respect to U.S. applications Ser. Nos. 09/777,151 and 9/777,559 which also claim priority of U.S. Ser. No. 09/527283.
Continuation in Parts (3)
|
Number |
Date |
Country |
Parent |
09527283 |
Mar 2000 |
US |
Child |
10004105 |
Dec 2001 |
US |
Parent |
09777151 |
Feb 2001 |
US |
Child |
10004105 |
Dec 2001 |
US |
Parent |
09777559 |
Feb 2001 |
US |
Child |
10004105 |
Dec 2001 |
US |